乳腺癌术后患者不同局部区域复发对预后的影响

doi:10.3969/j.issn.2095-378X.2020.03.001

Abstract

Abstract: Objective To evaluate the influences of different local regional recurrence （LRR） on prognosis of breast cancer patients after surgery. Methods The clinical data of 96 patients with breast cancer who received surgical treatment in the departments of breast surgery of the First Affiliated Hospital of Nanchang University and of Shanghai Wusong Hospital from January 2010 to December 2016 were analyzed retrospectively. According to the location of LRR, the patients were divided into three groups： ipilateral breast tumor recurrence （IBTR） group （n=33）, chestwall recurrence （CR） group （n=35）, and regional lymph node recurrence （LNR） group （n=28）. The clinical efficacy and overall survival （OS） of the two groups were compared, and the factors affecting the prognosis of LRR patients were analyzed by logistic regression. Results The objective remission rate of the CR group was 28.57%, significantly lower than that of the ITBR group （54.55%, P<0.05）. There were significant differences between the death group and the survival group in terms of pathological type, pathological stage, LRR, lymphatic metastasis, treatment mode （surgery, chemotherapy, and radiotherapy） after recurrence, and the expressions of ER, PR, and HER-2 （P<0.05）. Multiple logistic regression analysis results showed that pathological stage, HER-2 （positive）, and LRR （CR） were independent risk factors for prognosis of LRR patients with local recurrence after breast cancer surgery （P<0.05）, while surgery after LRR was an independent protective factor for prognosis （P<0.05）. Kaplan-Meier survival curve analysis results showed that the median OS of patients with different LRR locations from high to low were 50.76 months in the ITBR group （95% CI： 46.91-54.61）, 41.58 months in the LNR group （95% CI： 37.81-45.34）, and 33.28 months in the CR group （95% CI： 29.84-36.71）（χ²=15.10, P<0.05）. Conclusion LRR locations of postoperative breast cancer are closely related to prognosis, and ITBR shows a better therapeutic effect and prognosis. Active surgical resection of recurrent lesions is of great significance to prolong survival and improve prognosis of breast cancer patients with LRR.

Key words: Breast cancer, Local regional recurrence, Recurrence location, Prognosis

CLC Number:

JIN Hailong, WU Biao, ZHANG Yi. Influences of different local regional recurrence on prognosis of breast cancer patients after surgery[J]. Surgical Research and New Technique, 2020, 9(3): 149-153.

References

[1] Freddie B, Jacques F, Isabelle S, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. Cancer J Clin, 2018,68(6):394-424.
[2] 赵旭冉,王淑莲,宋永之,等.乳腺癌改良根治术后T_1-2N₁期患者局部区域复发的部位分析[J].中华放射肿瘤杂志,2020,29(1):31-34.
[3] Jegadeesh N K, Kim S, Prabhu R S, et al.The 21-gene recurrence score and locoregional recurrence in breast cancer patients[J]. Ann Surg Oncol, 2015, 22(4):1088-1094.
[4] 朱思吉, 陈小松, 吴佳毅, 等. 乳腺导管内癌外科治疗方式与预后的关系研究:单中心526例临床分析[J].中华外科杂志, 2017, 55(2):114-119.
[5] Eisenhauer E A, Therasse P, Bogaerts J, et al.New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)[J]. Eur J Cancer,2009,45(2):228-247.
[6] Harbeck N, Gnant M.Breast cancer[J].Lancet, 2017,389(10074):1134-1150.
[7] 吴松龄,张美泽,刘佳慧, 等.98例早期乳腺癌非前哨淋巴结转移的影响因素分析[J].外科研究与新技术,2020,9(1):6-9.
[8] Belkacemi Y, Hanna N E, Besnard C, et a1.Local and regional breast cancer recurrences:salvage therapy options in the new era of molecular subtypes[J]. Front Oncol, 2018, 8(5): 112-116.
[9] 吴晖,欧阳取长,谢宁,等.乳腺癌患者术后胸壁复发及预后相关因素分析[J].中华肿瘤防治杂志,2016,23(22):1498-1502.
[10] Lowery A J, Kell M R, Glynn R W, et al.Locoregional recurrence after breast cancer surgery:a systematic review by receptor phenotype[J]. Breast Cancer Res Treat,2012,133(3):831-841.
[11] Semrau S, Gerber B, Reimer T, et al.Concurrent radio-therapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer[J]. Strahlenther Onkol, 2006, 182(10):596-603.
[12] Wadasadawala T, Vadgaonkar R, Bajpai J.Management of isolated locoregional recurrences in breast cancer:a review of local and systemic modalities[J]. Clin Breast Cancer, 2017, 17(7):493-502.
[13] 金泽宇,陆裕杰,陈伟国,等.乳腺癌术后局部区域复发及再手术选择的相关因素分析[J].中华外科杂志,2019,57(5):366-372.
[14] Mendenhall W M, Shaw C, Amdur R J, et al.Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence[J].Am J Otolaryngol, 2013, 34(4): 225-234.

[1]	LU Xiaoliang, WU Bin, CHEN Keji, LI Aijun, FAN Fei. Expression of S100A7 in intrahepatic cholangiocarcinoma and its clinical significance [J]. Surgical Research and New Technique, 2021, 10(1): 4-8.
[2]	YAN Hailan. Effect of NOSES on left colon cancer and risk factors affecting prognosis [J]. Surgical Research and New Technique, 2020, 9(4): 228-230.
[3]	ZHOU Canhuan, LI Hongquan, LI Li, TAN Chaohua. Relationship between clinicopathologic features and prognosis of breast phyllodes tumor [J]. Surgical Research and New Technique, 2020, 9(4): 231-233.
[4]	LIU Jianxin, WANG Zheng, LI Jian. Efficacy, surgical outcome, and prognosis of patients with lumbar disc herniation after modified foraminoplasty [J]. Surgical Research and New Technique, 2020, 9(3): 166-169.
[5]	WU Songling, ZHANG Meize, LIU Jiahui, ZHAN Qiaohui. Factors of non-sentinel lymph node metastasis in 98 early breast cancer patients [J]. Surgical Research and New Technique, 2020, 9(1): 6-9.
[6]	WANG Yongliang, CHAI Hui, ZHAO Hongqing, WANG Huaijin, CHU Ruijun, GUO Siliang, ZHAI Yaojun. Effects of tamoxifen and anastrazole endocrine therapies for breast canceron bone metabolism [J]. Surgical Research and New Technique, 2019, 8(4): 262-264.
[7]	CHEN Manqing, WU Chunshan, SHE Danyu, FANG Zhichao, ZENG Canyi, XU Lishan. Application of axillary ultrasound combined with methylene blue in sentinel lymph node biopsy of breast cancer [J]. Surgical Research and New Technique, 2019, 8(3): 163-166.
[8]	HE Xue, YIN Peihao. Clinical value of General serum miR-21 detection in patients with colorectal cancer [J]. Surgical Research and New Technique, 2019, 8(1): 1-3.
[9]	CHEN Wenxiao, YUAN Chaojie, WU Weiwen, LUO Hai’an. Clinical application of auxiliary liposuction to axillary lymph node dissection [J]. Surgical Research and New Technique, 2019, 8(1): 40-43.
[10]	LI Yanling, LIU Peirong, ZHUANG Juhua, LU Weihua, PENG Sheng. Nursing intervention using auricular thumbtack needle buried for perioperative anxiety of patients undergoing breast cancer surgery [J]. Surgical Research and New Technique, 2018, 7(2): 143-145.
[11]	ZHANG Hui, LIN Mengbo, WANG Jinsi, CHEN Xiaogeng, FAN Yuezu, ZHENG Minhui. Clinical efficacy of nipple-sparing mastectomy and immediate breast reconstruction for early breast cancer patients [J]. Surgical Research and New Technique, 2018, 7(1): 4-8.
[12]	XU Ming, XIE Yiqun, ZHU Jiahui, HUANG Bin. Value of miR-155 and miR-21 in diagnosis of molecular subtypes of breast cancer [J]. Surgical Research and New Technique, 2017, 6(4): 229-234.
[13]	ZHANG Hui, LIN Mengbo, WANG Jinsi, CHEN Xiaogeng, FAN Yuezu. Effect of neoadjuvant chemotherapy on sentinel lymph node in breast cancer patients [J]. Surgical Research and New Technique, 2017, 6(4): 235-238.
[14]	MO Yongpan, YANG Yi. Application value of breast plastic surgery in breast conserving surgery for breast cancer [J]. Surgical Research and New Technique, 2017, 6(3): 155-157.
[15]	. Related factors of vascular tumor embolus in esophageal carcinoma [J]. Surgical Research and New Technique, 2016, 5(2): 108-110.

Influences of different local regional recurrence on prognosis of breast cancer patients after surgery

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments